| Type 2 Diabetes Mellitus |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Non-Alcoholic Fatty Liver Disease |
0 |
1 |
| Diabetic Microvascular Complications |
0 |
1 |
| Nephrogenic Systemic Fibrosis |
0 |
1 |
| Cardiovascular disease |
0 |
1 |
| Cardiovascular Risk Management |
0 |
1 |
| Metabolic Syndrome |
0 |
0.9 |
| Fatty Liver |
0 |
1 |
| Liver Disease |
0 |
1 |
| Liver |
0 |
1 |
| NHS |
0 |
0.45 |
| Renal Disease |
0 |
0.44 |
| Sudden Death |
0 |
0.33 |
| Chronic Kidney Disease |
0 |
1 |
| Renal Failure |
0 |
0.4 |
| Biomarker |
0 |
1 |
| Clinical Research |
0 |
0.4 |
| Endocrine Society |
0 |
0.4 |
| Endocrinology |
0 |
0.4 |
| Kidney |
0 |
0.4 |
| Retinopathy |
0 |
0.4 |
| Healthcare and Medical Technology |
0 |
0.4 |
| Retinal Diseases |
0 |
0.4 |